The wording of the announcement is intriguing, "Valuable...

The wording of the announcement is intriguing,
"Valuable insights and important learnings.........following interpretation of 4D medical Ventilation Reports by specialist thoracic radiologists and general practitioners".

No mention of "Thoracic Physicians, ie Respiratory Specialists.

These are currently the major group involved in the interpretation and usage of Lung Function Tests, which is one of the major "old tech" VLAS is designed to disrupt. Also the major clinical group responsible for the treatment of most major lung diseases.Suspect 4DX will need the interest and support of this clinician group to make significant inroads into other technologies and markets??.

The announcement specifically highlights response to "therapeutic interventions", which suggests perhaps trackable early changes in ventilation patterns which aren't necessarily seen by traditional methods?.

Also emphasises the importance of the relationship with NOVARTIS.(and therefore other pharmaceutical companies).

'Overwhelming enthusiasm from patients and radiologists' is one thing but I would like to see more "clinically meaningful utilisation", with commentary from clinicians who use the technology.

Its also intriguing that Casey has been chosen as the Melbourne site, its a very rapidly expanding health precinct, also has been especially affected by the COVID pandemic. Its also just one site!.

Gives a good insight into what we can expect once the US pilots start coming on line??.

IMHO
K